Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma Clinical Trials in Shanghai, Shanghai Municipality
3 recruitingShanghai, Shanghai Municipality, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Iparomlimab and Tuvonralimab in HNSCC
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University30 enrolled1 locationNCT07090317
Recruiting
Phase 2
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University39 enrolled1 locationNCT07088211
Recruiting
Phase 2
Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University98 enrolled1 locationNCT06935188